# AgeLens V2 Stage 5 Human Review

## Document Control

| Field | Value |
| --- | --- |
| Document ID | AL-V2-S5HR-001 |
| Version | 1.1 |
| Status | Completed |
| Date | 2026-07-24 |
| Decision | Pass with guardrails after corrective revision |
| Reviewed build | AgeLens-V2-Stage5-20260724b |

## Review Method

The review examined the complete Stage 5 change set, machine-readable tables, configurations, implementation and validation scripts, ARISE working materials, governance updates, and both generated figures. Numerical claims were checked against the released Stage 2–4 sources. Applying the release package records the project owner's acceptance of this review decision.

## Corrective Revisions Required Before Release

1. The independent validator was expanded from partial phrase and candidate-field checks to row-level reconciliation of all Stage 5 scientific-summary values, uncertainty intervals, multiplicity values, source hashes, abstract word count, claim states, document guardrails, disclosure controls, figure integrity, and Git change scope.
2. Machine-readable scientific-summary and claims-matrix sources now identify a source file plus a row or JSON field selector.
3. The ARISE working abstract now states directly that race/ethnicity is treated strictly as a social classification.
4. The V1-to-V2 progression figure now labels Stage 3 transportability as restricted and describes the prediction result as pooled out-of-cycle performance.

## Review Checklist

| Review item | Reviewer decision | Notes |
| --- | --- | --- |
| Stage 2 primary association and nonlinearity are both represented accurately | Pass | Global PR is retained only with explicit nonlinearity. |
| Secondary outcomes and Holm multiplicity are represented accurately | Pass | All three remain supportive secondary evidence. |
| Stage 3 transportability restrictions are retained | Pass | Race/ethnicity is explicitly a social classification; no biological, causal, or ranking claim. |
| Model C versus Model B prediction conclusion is accurate | Pass | Modest pooled out-of-cycle improvement within NHANES only. |
| Model D versus Model C negative incremental conclusion is retained | Pass | Confidence intervals permit small benefit or harm; no superiority or harm claim. |
| Model C remains preferred | Pass | Model D is not promoted. |
| Global EBM shape result is restricted to aggregate rank stability | Pass | No exact curve, threshold, effect-size, or local-explanation interpretation. |
| Causal, clinical, threshold, and individual-risk claims are absent | Pass | Prohibited-claim matrix and documents are consistent. |
| Figures avoid pooled numerical scales for incomparable estimands | Pass | Evidence panels are separated and explicitly non-pooled. |
| Abstract and presentation are appropriate working materials | Pass | Final submission remains a separate gate. |
| Aggregate-only disclosure and V1 immutability controls pass | Pass | No participant-level data or V1 changes were identified. |
| Independent validator provides meaningful post-build protection | Pass after revision | Row-level and document-level reconciliation added. |
| Final release and merge to main remain unauthorized | Pass | No final V2, manuscript, ARISE-submission, or main-merge authorization. |

## Decision

**Pass with guardrails after corrective revision.**

The Stage 5 aggregate synthesis and ARISE working materials may be committed to `v2-development` after the corrected release validator passes. Model C remains the preferred prediction model. Model D remains only a negative incremental-prediction result and restricted descriptive global-shape sensitivity.

This decision does **not** authorize final V2 release, final manuscript claims, final ARISE submission, or merge to `main`.
